Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


2nd Annual Market Access Oncology Forum

16 Oct 2012 - 17 Oct 2012 - Barcelona, Spain



Bookmark and Share


Fleming Europe is proud to organise its 2nd Annual Market Access Oncology Forum. On 16 – 17 October 2012 it is coming to Barcelona, Spain.

Invited expert speakers from pharma companies such as Celgene, Merck Serono, Amgen, J&J and non-industry speakers from INFARMED, HAS – SANTE, The World Bank, OECD and European Cancer Patient Coalition, will bring their valuable insights into the health care policy developments where the oncology market is maturing and access is increasingly restricted.

By joining us the attendees will learn how to:

- Create a strong value story to enhance the willingness to pay

- Customise your market access strategy

- Redefine the clinical trial process in order to meet the future demand for Value Based Medicine

- Optimally communicate value to all stakeholders

- Explore the concept of risk-sharing

- Benefit from the presence of HTA’s and maximise your chances at regulatory approval

For the event details, please request the event brochure http://pharma.flemingeurope.com/oncology-market-access/request-agenda



Further information
Scientific News
Wearable Microscope Can Measure Fluorescent Dyes Through Skin
UCLA research could make monitoring disease biomarkers easier and more cost-effective.
Potential of New Insect Control Traits in Agriculture
Researchers have discovered a protein that shows promise as an alternate corn rootworm control mechanism.
Fighting Cancer with Sticky Nanoparticles
Treatment that uses bioadhesive nanoparticles drug carriers proved more effective than conventional treatments for certain cancers.
Fighting Plant Pathogens with RNA
Researchers develop strategy that could lead to environmentally friendly fungicide to fight pathogens.
Smart Material Hunts Cancers
Team has created smart material that locates and images cancer or tumour sites in tissue.
Examining mtDNA May Help Identify Unknown Ancestry That Influences Breast Cancer Risk
Researchers studying mtDNA in a group of triple negative breast cancer patients found that 13 percent of participants were unaware of ancestry that could influence their risk of cancer.
Gene Therapy Technique May Help Prevent Cancer Metastasis
Gene-regulating RNA molecules could help treat early-stage breast cancer tumors before they spread.
Enhancing Antibiotics to Defeat Resistant Bacteria
Scientists enhance ability of antibiotics to defeat resistant types of bacteria using molecules called PPMOs
MRI Guidance Aids Stem Cell Delivery
Scientists have delivered stem cells to the brain with unprecedented precision, infusing the cells under real-time MRI guidance.
High-Capacity Nanoparticles
New type of nanoparticle can now have three or more drugs packaged within it, allowing for customised cancer therapy.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!